# Hagop M. Kantarjian, M.D., Houston, TX – FDA Inspections

Source: https://www.keypedia.com/companies/hagop-m-kantarjian-md/57a20198-e024-409a-b67e-d0b49222c3a9

> Inspection records and compliance data for Hagop M. Kantarjian, M.D. in Houston, Texas. 5 FDA inspections on record, 1 Form 483, last inspected March 16, 2018.

---

## Details

- Name: Hagop M. Kantarjian, M.D.
- FEI Number: 3003594742
- Address Line 1: 1515 Holcombe Blvd Unit 428
- City: Houston
- State: Texas
- Zip Code: 77030
- Country Name: United States
- Address: 1515 Holcombe Blvd Unit 428, Houston, Texas 77030, United States
- Country: United States

## Related Documents

- [EIR - Hagop M. Kantarjian, M.D. - 2018-03-16](https://www.keypedia.com/records/eir/hagop-m-kantarjian-md/31c284c1-661c-41cf-9869-4acb3d9f9565) — source: FDA, date: March 16, 2018
- FDA Inspection 1048237 - Hagop M. Kantarjian, M.D. - 2018-03-16 — classification: No Action Indicated (NAI), source: FDA, date: March 16, 2018
- [483 - Hagop M. Kantarjian, M.D. - 2017-05-05](https://www.keypedia.com/records/483/hagop-m-kantarjian-md/ede3cc71-0ef1-46b5-908a-e128be222fff) — source: FDA, date: May 5, 2017
- [FDA Inspection 1029979 - Hagop M. Kantarjian, M.D. - 2017-05-05](https://www.keypedia.com/records/fda_inspections/hagop-m-kantarjian-md/08493f8b-285f-4255-ba4d-0475c6e5c680) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 5, 2017
- FDA Inspection 898289 - Hagop M. Kantarjian, M.D. - 2014-09-17 — classification: No Action Indicated (NAI), source: FDA, date: September 17, 2014
- FDA Inspection 896497 - Hagop M. Kantarjian, M.D. - 2014-09-11 — classification: No Action Indicated (NAI), source: FDA, date: September 11, 2014
- [FDA Inspection 746460 - Hagop M. Kantarjian, M.D. - 2011-09-16](https://www.keypedia.com/records/fda_inspections/hagop-m-kantarjian-md/28ae3d8d-9664-418a-b943-68907bf72f9e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 16, 2011

## Related Companies

- [John D. Gabriel, MD](https://www.keypedia.com/companies/john-d-gabriel-md/6c8dab33-f0fe-48ec-8b27-7c62dededa1f)
- [Andapharm, LLC](https://www.keypedia.com/companies/andapharm-llc/62711f7a-0996-4623-93e4-87351349e6c9)
- [Nationwide Laboratories, LLC](https://www.keypedia.com/companies/nationwide-laboratories-llc/e5dccf31-f7a6-4a51-9f59-7e2929127933)
- [Shishuka Malhotra MD](https://www.keypedia.com/companies/shishuka-malhotra-md/01b66b3a-180c-4784-8210-0d1454be1832)
- [Mirum Pharmaceuticals, Inc.](https://www.keypedia.com/companies/mirum-pharmaceuticals-inc/9b906e94-ef88-467f-8b15-9f0b02d9e49d)
- [West Coast Cosmetics Inc](https://www.keypedia.com/companies/west-coast-cosmetics-inc/6d3129c0-b7de-4b7c-b7ee-f115624a9b8e)
- [Corden Pharma Boulder, Inc.](https://www.keypedia.com/companies/corden-pharma-boulder-inc/ac780a14-1ead-48c8-8376-cb62f7114aec)
- [Joseph L. Lillo, D.O.](https://www.keypedia.com/companies/joseph-l-lillo-do/1ea0d267-f3a4-4b8f-9611-61ba95abc6b1)
- [Dr. Reddy's Laboratories, Inc.](https://www.keypedia.com/companies/dr-reddys-laboratories-inc/ec3847d0-42b8-478b-bb7e-5e986389f184)
- [NuSil Technology LLC](https://www.keypedia.com/companies/nusil-technology-llc/ef176ca7-d941-4939-89a4-be78633f5cb4)

## Related Officers

- [Assistant Country Director, Regulatory Specialist BIMO](https://www.keypedia.com/people/alanna-l-mussawwir-bias/1283ff1a-34dd-4d90-9389-7bff2570527d)
- [company_representative](https://www.keypedia.com/people/monica-i-kwari/2546655d-5b0f-4f97-924d-f31b23f151bb)
- [recipient](https://www.keypedia.com/people/hagop-m-kantarjian/541c9359-7255-40e8-8705-8713c999d646)
